697 related articles for article (PubMed ID: 15544617)
1. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
3. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
Kita-Furuyama M; Nagayama Y; Pichurin P; McLachlan SM; Rapoport B; Eguchi K
Clin Exp Immunol; 2003 Feb; 131(2):234-40. PubMed ID: 12562382
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.
Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS
Endocrinology; 2006 Jan; 147(1):111-9. PubMed ID: 16195404
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.
Saitoh O; Mizutori Y; Takamura N; Yamasaki H; Kita A; Kuwahara H; Nagayama Y
Clin Exp Immunol; 2005 Sep; 141(3):405-11. PubMed ID: 16045729
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.
Land KJ; Moll JS; Kaplan MH; Seetharamaiah GS
Endocrinology; 2004 Aug; 145(8):3724-30. PubMed ID: 15117875
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
Ueki I; Abiru N; Kawagoe K; Nagayama Y
J Endocrinol; 2011 Jun; 209(3):353-7. PubMed ID: 21474590
[TBL] [Abstract][Full Text] [Related]
10. Immune deviation away from Th1 in interferon-gamma knockout mice does not enhance TSH receptor antibody production after naked DNA vaccination.
Pichurin P; Pichurina O; Chazenbalk GD; Paras C; Chen CR; Rapoport B; McLachlan SM
Endocrinology; 2002 Apr; 143(4):1182-9. PubMed ID: 11897670
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
[TBL] [Abstract][Full Text] [Related]
12. Graves' hyperthyroidism and the hygiene hypothesis in a mouse model.
Nagayama Y; McLachlan SM; Rapoport B; Oishi K
Endocrinology; 2004 Nov; 145(11):5075-9. PubMed ID: 15308620
[TBL] [Abstract][Full Text] [Related]
13. Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease.
Chen CR; Pichurin P; Chazenbalk GD; Aliesky H; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Jan; 145(1):228-33. PubMed ID: 14576177
[TBL] [Abstract][Full Text] [Related]
14. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Horie I; Abiru N; Saitoh O; Ichikawa T; Iwakura Y; Eguchi K; Nagayama Y
Autoimmunity; 2011 Mar; 44(2):159-65. PubMed ID: 20670120
[TBL] [Abstract][Full Text] [Related]
15. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
16. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
Seetharamaiah GS; Land KJ
Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
[TBL] [Abstract][Full Text] [Related]
17. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease.
Dogan RN; Vasu C; Holterman MJ; Prabhakar BS
J Immunol; 2003 Feb; 170(4):2195-204. PubMed ID: 12574393
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
Saitoh O; Nagayama Y
Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
[TBL] [Abstract][Full Text] [Related]
19. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
20. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
Pichurin P; Aliesky H; Chen CR; Nagayama Y; Rapoport B; McLachlan SM
Clin Exp Immunol; 2003 Dec; 134(3):396-402. PubMed ID: 14632743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
